리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 08월
페이지 정보:영문 486 Pages
라이선스 & 가격 (부가세 별도)
한글목차
벤더 중립 아카이브(NVA) 및 의료영상 저장전송시스템(PACS) 세계 시장은 2030년까지 65억 달러에 도달
2023년에 41억 달러로 추정되는 벤더 중립 아카이브(NVA) 및 의료영상 저장전송시스템(PACS) 세계 시장은 2023-2030년간 CAGR 6.7%로 성장하여 2030년에는 65억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 의료영상 저장전송시스템(PACS)은 CAGR 5.8%를 나타내고, 분석 기간 종료시에는 44억 달러에 이를 것으로 예측됩니다. VNA 소프트웨어 분야의 성장률은 분석 기간에 CAGR 8.8%로 추정됩니다.
미국 시장은 13억 달러, 중국은 CAGR 8.0%로 성장 예측
미국의 벤더 중립 아카이브(NVA) 및 의료영상 저장전송시스템(PACS) 시장은 2023년에 13억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 4억 6,910만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2023-2030년간 CAGR은 8.0%입니다. 기타 주목해야 할 지역 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 5.8%와 5.7%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 5.9%를 나타낼 전망입니다.
세계 벤더 중립 아카이브(NVA) 및 PACS 시장 - 주요 동향 및 촉진요인 요약
벤더 중립 아카이브(VNA)와 영상저장통신시스템(PACS)은 의료 영상 및 관련 데이터를 저장, 검색 및 관리할 수 있는 헬스케어 분야의 핵심 구성 요소로, PACS는 엑스레이, MRI, CT 스캔 등 다양한 영상 데이터를 저장, 검색 및 관리할 수 있는 통합 플랫폼을 제공합니다. 저장하고 접근할 수 있는 중앙 집중식 플랫폼을 제공하여 효율적인 워크플로우와 환자 치료 개선을 촉진합니다. 반면, VNA는 의료 서비스 제공업체가 여러 PACS 시스템 및 기타 소스의 영상 데이터를 통합하여 관리할 수 있는 벤더 독립적인 의료 영상 저장소를 제공하는 보다 진보된 솔루션입니다. 이러한 상호운용성을 통해 서로 다른 진료과와 의료 시설 간에 환자 정보에 대한 원활한 접근을 보장하여 임상적 의사결정과 업무 효율성을 향상시킬 수 있습니다.
VNA와 PACS의 도입은 의료 영상 데이터 증가와 효율적인 데이터 관리 솔루션의 필요성에 의해 추진되어 왔습니다. 아날로그 영상에서 디지털 영상으로의 전환은 진단 능력을 크게 향상시켰지만, 데이터 저장, 검색 및 상호운용성 문제를 야기하고 있으며, VNA는 서로 다른 영상 시스템을 통합하고 장기적인 데이터 접근성을 보장하는 통합 플랫폼을 제공함으로써 이러한 문제를 해결합니다. 해결합니다. 또한, 원격 의료와 원격 진단의 부상으로 접근 가능하고 공유 가능한 영상 데이터의 중요성이 강조되고 있습니다. 클라우드 컴퓨팅과 사이버 보안의 발전으로 VNA 및 PACS 솔루션의 기능과 보안이 더욱 강화되어 확장성과 내결함성이 향상되고 있습니다.
벤더 중립 아카이브(NVA) 및 PACS 시장의 성장은 몇 가지 요인에 의해 이루어지고 있습니다. 첫째, 의료 영상 데이터 증가와 디지털 영상으로의 전환으로 인해 효율적인 데이터 관리 솔루션에 대한 수요가 증가하고 있습니다. 둘째, 서로 다른 의료 시스템 및 시설 간의 상호 운용성과 원활한 데이터 통합의 필요성이 VNA의 채택을 촉진하고 있습니다. 셋째, 클라우드 컴퓨팅과 사이버 보안의 발전으로 VNA와 PACS 솔루션의 확장성, 접근성 및 보안이 강화되고 있습니다. 마지막으로, 원격 의료 및 원격 진단의 확대는 접근 가능하고 공유 가능한 영상 데이터의 중요성을 강조하며 이러한 기술 시장을 더욱 촉진하고 있습니다. 이러한 요인들이 종합적으로 VNA 및 PACS 시장의 견조한 성장에 기여하고 있습니다.
조사 대상 기업 예(총 155개사)
Agfa Healthcare NV
Advanced Data Systems Corporation(ADS)
AMD Technologies, Inc.
ASPYRA LLC
Birlamedisoft Pvt., Ltd.
21st Century Informatics BV
Avreo, Inc.
b.e. imaging GmbH
Biomedical Equipment Corporation
Bridgehead Software
ACG Infotech Ltd.
Adroit Infosystems
ATMC Co., Ltd.
Ashva Digital Healthcare
Allengers Infotech
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
월드 브랜드
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
세계 기타 지역
제4장 경쟁
LSH
영문 목차
영문목차
Global Vendor Neutral Archive (VNA) and PACS Market to Reach US$6.5 Billion by 2030
The global market for Vendor Neutral Archive (VNA) and PACS estimated at US$4.1 Billion in the year 2023, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. PACS, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.4 Billion by the end of the analysis period. Growth in the VNA Software segment is estimated at 8.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 8.0% CAGR
The Vendor Neutral Archive (VNA) and PACS market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$469.1 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.
Global Vendor Neutral Archive (VNA) and PACS Market - Key Trends & Drivers Summarized
Vendor Neutral Archive (VNA) and Picture Archiving and Communication System (PACS) are critical components in the healthcare sector, enabling the storage, retrieval, and management of medical images and associated data. PACS provides a centralized platform for storing and accessing imaging data from various modalities, such as X-rays, MRIs, and CT scans, facilitating efficient workflow and improved patient care. VNA, on the other hand, is a more advanced solution that offers a vendor-agnostic repository for medical images, allowing healthcare providers to integrate and manage imaging data from multiple PACS systems and other sources. This interoperability ensures seamless access to patient information across different departments and healthcare facilities, enhancing clinical decision-making and operational efficiency.
The adoption of VNA and PACS has been driven by the increasing volume of medical imaging data and the need for efficient data management solutions. The transition from analog to digital imaging has significantly improved diagnostic capabilities, but it has also created challenges related to data storage, retrieval, and interoperability. VNA addresses these challenges by providing a unified platform that can integrate disparate imaging systems and ensure long-term data accessibility. Additionally, the rise of telemedicine and remote diagnostics has underscored the importance of accessible and shareable imaging data. Advancements in cloud computing and cybersecurity are further enhancing the capabilities and security of VNA and PACS solutions, making them more scalable and resilient.
The growth in the Vendor Neutral Archive (VNA) and PACS market is driven by several factors. Firstly, the increasing volume of medical imaging data and the shift towards digital imaging are creating a demand for efficient data management solutions. Secondly, the need for interoperability and seamless data integration across different healthcare systems and facilities is driving the adoption of VNA. Thirdly, advancements in cloud computing and cybersecurity are enhancing the scalability, accessibility, and security of VNA and PACS solutions. Lastly, the expansion of telemedicine and remote diagnostics is highlighting the importance of accessible and shareable imaging data, further boosting the market for these technologies. These factors collectively contribute to the robust growth of the VNA and PACS market.
Select Competitors (Total 155 Featured) -
Agfa Healthcare NV
Advanced Data Systems Corporation (ADS)
AMD Technologies, Inc.
ASPYRA LLC
Birlamedisoft Pvt., Ltd.
21st Century Informatics BV
Avreo, Inc.
b.e. imaging GmbH
Biomedical Equipment Corporation
Bridgehead Software
ACG Infotech Ltd.
Adroit Infosystems
ATMC Co., Ltd.
Ashva Digital Healthcare
Allengers Infotech
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Vendor Neutral Archive (VNA) and PACS - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Information Technology Revolutionizes Healthcare Industry
PACS and VNA: A Prelude
Picture Archiving and Communication System (PACS)
Vendor Neutral Archive (VNA)
VNA Characteristics
Factors Driving Growth
Market Outlook
On-Premise Model Rules VNA & PACS Market, while Hybrid VNA Posts Robust Growth
Market Witnesses Expedited Shift towards Cloud
Regional Landscape
Recent Market Activity
WORLD BRANDS
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Vendor Neutral Archiving Takes Over Storage Functionality of PACS
VNA Addresses DICOM Issues with PACS
Ramping up of Digitization of Global Healthcare Systems and Growing Need for Medical Archiving Drives Demand for PACS and VNA Platforms
Increasing Volumes of Big Data in Healthcare and Rising Need for Medical Image Archiving Generates Demand for VNA
Global Healthcare Data Generated: 2014, 2020, and 2025 (in exabytes)
New Storage Options to Deal with Burgeoning Imaging Data
Demand for Integrated RIS/PACS Solutions Surges High
SaaS and Cloud Based Models - Key to Increasing Penetration of PACS and RIS
Artificial Intelligence Integration Emerges as Buzzing Trend for PACS
Global Healthcare Artificial Intelligence Market by Application: 2023
Technology Advancements Fuel Demand for Replacement Systems
Cloud PACS Takes Imaging to the Cloud & Grows in Prominence
Benefits offered by Cloud-Based PACS
Better Speed & Workflow Adaptations: Key Features of New Platforms
Secure Cloud PACS Enjoys Real Moment with Emergence of AI & Machine Learning
Sophisticated VNA Harmonizes Clinical Data to Yield True Health Data Library
Compelling Merits of Advanced NVAs over Traditional Ones
Other PACS, VNA Advancements
New Systems Designed to Offer Better Integration with Third-Party Applications
How Implementation of Integrated IT Solutions is Benefitting Cardiology Departments
Growth in Mobile Imaging Drives Installations
Increase in Healthcare Spending to Propel Demand
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Ageing Population and Growth in Imaging Procedure Volumes to Support Growth
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Third-party Middleware Offerings to Make Inroads into Enterprise PACS Market
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Vendor Neutral Archive (VNA) and PACS Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Vendor Neutral Archive (VNA) and PACS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for PACS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for PACS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for PACS by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for VNA Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for VNA Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for VNA Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Vendor Neutral Archive (VNA) and PACS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 29: USA Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Vendor Neutral Archive (VNA) and PACS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 47: Japan Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 53: Japan Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Vendor Neutral Archive (VNA) and PACS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 56: China Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: China 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 59: China Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: China Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: China 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Vendor Neutral Archive (VNA) and PACS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 65: Europe Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Vendor Neutral Archive (VNA) and PACS by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Europe 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
TABLE 77: France Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: France Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: France 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 80: France Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: France Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: France 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 83: France Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
TABLE 86: Germany Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Germany Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Germany 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 89: Germany Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Germany Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Germany 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 92: Germany Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 95: Italy Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Italy Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Italy 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 98: Italy Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Italy Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Italy 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 101: Italy Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
TABLE 104: UK Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: UK Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: UK 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 107: UK Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: UK Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: UK 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 110: UK Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: Rest of Europe Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: Rest of Europe 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: Rest of Europe Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Rest of Europe 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Rest of Europe Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Rest of Europe 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Vendor Neutral Archive (VNA) and PACS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Asia-Pacific Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Asia-Pacific 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Asia-Pacific Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Asia-Pacific 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Asia-Pacific Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Asia-Pacific 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 131: Rest of World Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of World Historic Review for Vendor Neutral Archive (VNA) and PACS by Type - PACS and VNA Software Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Rest of World 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Type - Percentage Breakdown of Value Revenues for PACS and VNA Software for the Years 2014, 2024 & 2030
TABLE 134: Rest of World Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of World Historic Review for Vendor Neutral Archive (VNA) and PACS by Deployment - On-Premise, Hybrid and Cloud Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of World 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by Deployment - Percentage Breakdown of Value Revenues for On-Premise, Hybrid and Cloud for the Years 2014, 2024 & 2030
TABLE 137: Rest of World Recent Past, Current & Future Analysis for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of World Historic Review for Vendor Neutral Archive (VNA) and PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of World 16-Year Perspective for Vendor Neutral Archive (VNA) and PACS by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2014, 2024 & 2030
